期刊文献+

白细胞介素-1β对胆囊癌细胞生长和迁移的影响 被引量:2

Effects of IL-1 β on proliferation and migration of gallbladder cancer cells
原文传递
导出
摘要 目的探讨白细胞介素-1β(IL-1β)对胆囊癌细胞生长、迁移和侵袭的影响。方法ELISA法检测胆囊癌、慢性胆囊炎组织、正常胆囊组织标本以及细胞培养基中IL-1β的含量;实时-PCR技术检测IL-1β在胆囊癌细胞株(GBC-SD和SGC996)和肝内胆管上皮细胞株HIBEpic中的表达水平;采用WST-1法和动物模型检测IL-1β在体内和体外对胆囊癌细胞生长的影响;采用Transwell试验检测胆囊癌细胞迁移能力改变;实时-PCR和蛋白印迹法检测IL-1β作用后Twist基因表达水平,并在沉默Twist基因表达后进一步检测IL-1β对细胞生长和迁移的作用。结果IL-1β在胆囊癌和慢性胆囊炎组织标本中含量[(616.4±95.7)pg/ml和(422.3±48.9)pg/ml]远远高于胆囊正常组织[(66.4±35.0)pg/ml,P〈0.05];IL-1β在GBC-SD和SGC996细胞培养液中的含量[(587.4±99.8)pg/ml和(657.2±76.6)pg/ml]高于HIBEpic[(38.4±12.1)pg/ml,P〈0.05];加入外源性重组IL-1β可以显著促进GBC-SD和SGC996细胞的生长和迁移(P〈0.05);外源性IL-1β可以诱导Twist表达升高。沉默Twist表达,外源性IL-1β无法促进胆囊癌细胞生长和迁移。结论IL-1β通过诱导Twist基因表达促进胆囊癌细胞生长和转移。 Objective To investigate the effects of -1β on proliferation and migration of gallbladder cancer cells. Methods The secretion of -1β in tissues of gallbladder cancer, chronic cholecystitis and normal gallbladder as well as in supernatant of gallbladder cancer cell lines ( GBC-SD, SGC996) and HIBEpic cells was determined by enzyme-linked immunosorbent assay (ELISA) method. The levels of -1β mRNA in GBC-SD, SGC996 and HIBEpic cells were measured by RT-PCR assay. The effects of exogenous IL-1β on the proliferation of GBC-SD and SGC996 cells in vitro and in vivo were evaluated using WST-1 assay and xenograft tumor model, respectively. The effects of exogenous -1β on the migration of GBC-SD and SGC996 cells in vitro were measured by Tranwell assay. The levels of Twist protein in GBC-SD and SGC996 cells were examined by western blot assay after treatment with exogenous IL-1 β. In addition, the proliferation and migration of GBC-SD and SGC996 cells after gene silencing of Twist by Twist-siRNA were also evaluated. Results The level of -1β protein in normal gallbladder was low ( 66.4 ± 35.0) pg/ml, while it was significantly increased in gallbladder cancer and chronic cholecystitis [ (616. 4 ± 95. 7 ) pg/ml and (422.3 ±48.9)pg/ml, P 〈 0.05 ]. The levels of IL-1β in GBC-SD and SGC996 cell culture medium [ ( 587.4 ± 99.8 ) pg/ml and ( 657.2 ±76.6 ) pg/ml ] were much higher than those in the HIBEpic cells [ (38.4 ± 12.1 )pg/ml, P 〈 0.05 ]. Exogenous -1β promoted the proliferation of GBC-SD and SGC996 cells both in vitro and in vivo as well as migration in vitro ( P 〈 0.05 ). The level of Twist protein was significantly increased after treatment with exogenous IL-1 β. In addition, gene silencing of Twist blocked IL-1 β- induced proliferation and migration of GBC-SD and SGC996 cells. Conclusion IL-1β promoted proliferation and migration of gallbladder cancer cells via Twist activation.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第12期821-825,共5页 Chinese Journal of Hepatobiliary Surgery
基金 上海医药高等专科学校基金(201421008) 上海市青年医师培养基金(AB83190002012023) 上海市重点专科基金(ZK2012A15)
关键词 白细胞介素-1Β TWIST基因 胆囊癌 Interleukin-1 Twist gene Gallbladder cancer
  • 相关文献

参考文献17

  • 1李静静,刘卫,曲强,洪涛,徐协群,李秉璐,王莹,何小东.胆囊癌患者151例新版TNM分期的临床评估[J].中华肝胆外科杂志,2014,20(7):507-510. 被引量:22
  • 2包万员,佘刚,朱峰.胆道系统肿瘤的化疗现状与进展[J].中华肝胆外科杂志,2014,20(10):758-761. 被引量:17
  • 3Chen W, Gao Q, Han S, ct al. The CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal transition by cooperatively activating STAT3-Twist signaling [ J ]. Tumour Biol, 2015, 36 (2) :973-981.
  • 4Li LZ, Zhang CZ, Liu LL, et al. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1 [ J ]. Carcinogenesis, 2014,35 ( 2 ) :469-478.
  • 5Qian J, Luo Y, Gu X, et al. Twistl promotes gastric cancer cell proliferation through up-regutatiou of FoxM1 [ J ]. PLoS One, 2013,8(10) : e77625.
  • 6Yamada S, Okumura N, Wei L, et al. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepato- cellular carcinoma [ J ]. Ann Surg Oncol, 2014, 21 ( 12 ) : 3882-3890.
  • 7Kim YH, Kim G, Kwon CI, et al. TWIST1 and SNAIl as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1 [ J ]. Oncol Rep, 2014, 31 (3) :1380-1388.
  • 8Zhang YQ, Wei XL, Liang YK, et al. Over-expressed Twist asso- ciates with markers of epithelial mesenchymal ransition and pre- dicts poor prognosis in breast cancers via ERK and Akt activation [J]. PLoS One, 2015,10(8) :e0135851.
  • 9Han J, Xie Y, Lan F, et al. Additive effects of EGF and IL-1β regulate tumor cell migration and invasion in gastric adenocarcino- ma via activation of ERK1/2 [ J ]. lnt J Oncol, 2014,45 ( 1 ) : 291-301.
  • 10Lei YM, Zu YF, Wang J, et al. Interleukin-1 β-mediated suppres- sion of microRNA-101 and upregulation of enhancer of zeste homo- log 2 is involved in particle-induced lung cancer[ J]. Med Oncol, 2015,32( 1 ) :387.

二级参考文献40

  • 1Yang XW, Yang J, Li L, et al. Analysis of the relationships be- tween clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent [ J ]. Plos One, 2012,7(12) :e51513.
  • 2Yuan Y, Yang ZL, Zou Q, et al. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 ex- pression in benign and malignant lesions of the gallbladder [J].Polish J Pathology,2013,64( 1 ) :44-51.
  • 3Boutros C, Gary M, Baldwin K, et al. Gallbladder cancer: past, present and an uncertain future [J].Surg Onct)log ( Oxford), 2012,21 (4) :e183-191.
  • 4D'handt M, Lapointe R, Benamira Z, et al. Carcinoma of the gall- bladder: Patterns of presentation, prognostic factors and survival rate: an ll-year single centre experience [ J ]. Ejso, 2013,39 (6) :548-553,.
  • 5Meng H, Wang X, Fong Y, et at. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases [ J ]. Jap J Clin Oneol,2011,41 (8) :992-998.
  • 6Sakamoto Y, Nara S, Kishi Y, et al. ls extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? [ J ]. Surgery, 2013,153 (6) : 794 -800.
  • 7Horignchi A, Miyakawa S, Ishihara S,et al. Gallbladder bed resec- tion or hepatectomy of segments 4a and 5 for pT2 gallbladder car- cinoma: analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pan- creatic Surgery [ J]. J Hepato Biliary Pancreatic Sci,2013,20 (5) :518-524.
  • 8Vauthey JN,Blumgart LH.Recent advances in the management of cholangiocarcinomas[J] .Semin Liver Dis,1994,14 (2):109-114.
  • 9Braconi C,Patel T.Cholangiocarcinoma:new insights into disease pathogenesisandbiology[J] .Infect Dis Clin North Am,2010,24(4):871-884.
  • 10Seehofer D,Kamphues C,Neuhaus P.Management of bile duct tumors[J] .Expert Opin Pharmacother,2008,9 (16):2843-2856.

共引文献36

同被引文献8

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部